发明名称 核内受容体結合薬
摘要 The present invention relates to methods for prevention and/or treatment of metabolic disorders, post-menopausal obesity and conditions associated with high fat diet consumption including, obesity, body weight gain, fat mass formation, bone mineral content reduction, white adipose tissue weight gain, increased cholesterol levels, increased leptin levels, insulin resistance, type II diabetes, increased blood glucose levels, inflammatory diseases, cardiovascular diseases, fatty liver condition (accumulation of fat in the liver), decreased uncoupling protein-1 (UCP-1) levels and increased lipogenesis.
申请公布号 JP5792799(B2) 申请公布日期 2015.10.14
申请号 JP20130509219 申请日期 2011.05.04
申请人 ジーティーエックス・インコーポレイテッド 发明人 ナラヤナン、ラメシュ;イェプル、ムラリモハン;ダルトン、ジェームズ・ティー
分类号 A61K31/472;A61K31/4725;A61P1/16;A61P3/04;A61P3/06;A61P3/10;A61P5/30;A61P9/00;A61P9/12;A61P15/12;A61P19/02;A61P29/00;A61P43/00 主分类号 A61K31/472
代理机构 代理人
主权项
地址